Abbott Says Timing Mismatch Lets $8B Gain Go Untaxed

Abbott Laboratories asked the U.S. Tax Court to find that it needn't recognize an $8 billion gain in 2020 from transactions between several of its controlled foreign corporations because of a...

Already a subscriber? Click here to view full article